Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...

Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for its ...

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...

Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square ...

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the ...

The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...

Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility ...

People living with rare diseases are being offered two years’ free access to an AI-powered app that captures medical ...